Genprex, Inc. (GNPX) Stock Forecast
GNPX analyst forecast
as of October 17, 2026- Analyst consensus
- —
- Price target
- $7.50 average of analyst targets
- Upside to target
- +255.5% from the latest close
- Next earnings
- November 13, 2026
- 52-week range
- $2.11 – $308.00
GNPX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
GNPX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next fiscal year (2026) | −$1.15 | −$1.15 | −$1.15 | −$1.25 | +8.0% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
GNPX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next fiscal year (2026) | $0 | $0 | $0 | — | — |
GNPX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
GNPX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next fiscal year (2026) | −$1.35 | −$1.35 | −$1.35 | −$1.35 | −$1.15 | −14.8% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
GNPX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; GNPX beat in 2 of 9.
What analysts expect from GNPX
The average price target is $7.50, 255.5% above the latest close of $2.11. For 2026 the average estimate is −$1.15 per share. Genprex beat the EPS estimate in 2 of the last 9 quarters.
Related: GNPX income statement, GNPX key metrics, GNPX chart. See the GNPX stock overview for the latest quote and news.
GNPX forecast FAQ
What is Genprex's price target?
The average analyst price target for Genprex is $7.50, 255.5% above the latest close of $2.11.
When does Genprex report earnings?
Genprex is expected to report results for the quarter ending September 30, 2026 on November 13, 2026.
Does Genprex usually beat earnings estimates?
Genprex reported EPS at or above the analyst estimate in 2 of the last 9 quarters.